Cipla beats Q1 profit view on robust demand Ruchika Sharma27 July 2024 3:07 PM ISTHyderabad: Drugmaker, Cipla, has exceeded profit expectations for the first quarter of the fiscal year, driven by a significant increase in sales...
Both components of albuterol-budesonide combo contribute to lung function efficacy in mild-to-moderate asthma Aditi8 July 2023 9:00 AM ISTA study published in CHEST Journal has concluded that both Albuterol and budesonide contribute to the albuterol-budesonide combination's lung function...
AstraZeneca PT027 recommended by FDA advisory committee as new rescue treatment for asthma Ruchika Sharma9 Nov 2022 1:30 PM ISTAsthma is a chronic, inflammatory, variable respiratory disease that affects as many as 339 million people worldwide, including over 25 million in the...
Albuterol and budesonide combo reduces risk of severe asthma exacerbations: NEJM Dr. Kamal Kant Kohli17 May 2022 8:00 PM ISTA global study of asthma patients by Rutgers and an international team of researchers found a combination of two drugs dramatically reduces the...
Ex-Pharma CEO aided opioid sales to addicts, US says Ruchika Sharma20 Jan 2022 5:24 PM ISTNew Delhi: The former head of a major generic drug distributor directed U.S. sales of opioids to pharmacies despite "serious red flags" that the...
No benefit of nebulized magnesium with albuterol in reractory pediatric asthma: JAMA Dr. Kamal Kant Kohli26 Nov 2020 4:15 PM ISTA recent study in children with refractory acute asthma showed nebulized magnesium with albuterol, compared with placebo with albuterol, did not...
Lupin reports net profit at Rs 211 crore in Q2 Ruchika Sharma7 Nov 2020 9:00 AM ISTNew Delhi: Drug firm Lupin has reported a consolidated net profit of Rs 211.02 crore for the quarter ended September 30, 2020 mainly on account of...
